Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 (v3.4.3 removed).
    Difference
    0.1%
    Check dated 2026-03-19T04:57:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page metadata.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:53.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Minor site maintenance updates were applied: Revision v3.4.2 added and the earlier notices (including Revision v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:18:21.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about funding status and operating status was added, and the release notes show Revision: v3.4.1. These updates do not alter the study content or its reported information.
    Difference
    0.4%
    Check dated 2026-02-04T06:54:06.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated the QC-related labels to reflect the latest revision (Last Update Submitted that Met QC Criteria and Revision: v3.4.0), while older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.2%
    Check dated 2026-01-28T04:59:25.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3. This is a metadata version update and does not modify study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-01-14T02:31:42.000Z thumbnail image

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.